LabCorp IT Security Information

During the weekend of July 14, 2018, LabCorp detected suspicious activity on its information technology network. The activity was subsequently determined to be a new variant of ransomware, which is an attempt to lock or disable computers and servers to prevent access to data. LabCorp promptly took certain systems offline as part of its comprehensive response to contain and remove the ransomware from its system. This temporarily affected test processing and access to test results. Operations have returned to normal.

The ransomware was detected only on LabCorp Diagnostics systems; Covance Drug Development systems were not affected by the ransomware.

As part of our in-depth and ongoing investigation into this incident, LabCorp has engaged outside security experts and is working with authorities, including law enforcement. The investigation has found no evidence of theft or misuse of customer or patient data.

We are confident that this ransomware did not and cannot spread to customer networks. LabCorp blocked the ransomware and enhanced our security measures, and thus we are confident that this particular ransomware cannot re-emerge on the LabCorp network.

LabCorp takes data privacy and security very seriously and has robust security systems, protocols, and redundancies in place. We responded quickly and decisively to protect our patient and customer data and to resume operations. We appreciate your patience through this process.